Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 1997

View Archived Issues

MGI Pharma: Q3 1997 highlights

Bone Care: Q3 1997 highlights

Lilly: Q3 1997 highlights

BioCryst: Q3 1997 highlights

Atlantic's 2-5A improves efficacy of antisense compounds

First report of efficacy for rotavirus vaccine in a developing country

ADCON-L up for advisory committee review

Dusa reports positive phase III results for Levulan PDT

Hyal invests in breast cancer detection technology

Major advance in thalassemia research reported

Alza acquires rights to Ditropan

TBC-1269 enters phase II for treatment and prevention of asthma

Nicotrol launched in Austria as OTC

VEGF inhibitors described by Zeneca

Janssen discloses agents that promote gastrointestinal motility

New antidiabetic agents from Boehringer Mannheim

Abbott develops inhibitors of LT biosynthesis

Improved DNA topoisomerase poisons discovered at Rutgers

Anti-H. pylori cephems claimed by Fujisawa

New antimitotic agents presented by Kyowa Hakko

New DC-107 derivative presented at cancer meeting

Cellular target of new antitumor agent from Nippon Shinyaku identified

Nikken presents new modulator of multidrug resistance

NCA-0465: new antitumor indoloquinoxaline derivative

Preclinical studies on TZT-1027, an antitumor dolastatin 10 derivative

Taiho reports preclinical studies on TAS-103

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Development of antipsychotic agent discontinued

Synthetic retinoid with antiangiogenic/apoptosis-inducing effects from Taiho

MS-209 reverses MDR mediated by MRP and P-glycoprotein

Jenner Technologies changes name

Photofrin now available in France and Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...